It seems that rare or orphan disease haven't been properly addressed since there is a lack of data. Some witnesses have told us that it might be a good idea to look at international data. That way, we would have a better idea of the effectiveness of a product.
Do you think it would be a good thing to increase our consideration of certain drugs? Or should we simply be more open-minded about ways to treat rare or orphan diseases?